Clinical Trial Update: Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery [Phase 4]

View source ↗

Summary

Clinical trial update on the effects of an SGLT2 inhibitor in patients with type 2 diabetes undergoing cardiac surgery (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hongchang Guo | Conditions: Diabetes Mellitus, Type 2, Cardiac Surgery | Phase 4 | Status: UNKNOWN